
Medical ‘Match Day’ celebration returns in person
For the first time since 2019, fourth-year medical students at the University of Rochester celebrated Match Day in person.

Rochester researchers seek ‘direct hit’ on leukemic stem cells
An internal funding program, plus the close proximity of the University’s engineering and medical facilities, promotes progress in a potential treatment for acute myeloid leukemia.

Will hearing aids ever be as effective as corrective eyewear?
Despite recent advances in hearing aid technology, users frequently complain that the devices tend to amplify all the sounds around them. Rochester researcher Jong-Noon Nam believes a key part of the answer to this problem lies inside the cochlea of the inner ear.

New imaging technology could buy time for pancreatic cancer patients
Tumor shrinkage is one sign of cancer treatment’s efficacy—but Rochester scientists are exploring elasticity and permeability as well.

Software uses selfies to detect early symptoms of Parkinson’s disease
Rochester computer scientist Ehsan Hoque and his colleagues have harnessed machine learning to accurately identify signs of the neurological disease by analyzing facial muscles.

Smaller is better for detecting biomarkers of trauma and cancer
Detecting tiny biomarkers circulating in our bodies is problematic and costly. Researchers are developing a cost-effective detection device using nanotechnology.

A new way to prepare doctors for difficult conversations
University of Rochester researchers have developed SOPHIE, a virtual ‘patient’ that trains doctors in explaining end-of-life options.

New study mismatches vaccine doses to boost immunity to COVID-19 and variants
The Medical Center is participating in a new clinical trial that mixes and matches the initial regime of an approved COVID-19 vaccine with a booster from a different manufacturer.

First-ever lab model of human eye offers hope for macular degeneration patients
Rochester researchers’ breakthrough could lead to patient-specific treatments for age-related macular degeneration, which leads to a loss of central vision.

An experimental neurofeedback imaging treatment has emerged for psychiatric patients. Does it work?
A study by University of Rochester psychologists finds some positive results for the new approach.